Crossmark

Long-Term Ivacaftor in People Aged 6 Years and Older with Cystic Fibrosis with Ivacaftor-Responsive Mutations

Published Online: 2020-09-23

Published Print: 2020-12

Authors

Pilewski, Joseph M.

De Boeck, Kris

Nick, Jerry A.

Tian, Simon

DeSouza, Cynthia

Higgins, Mark

Moss, Richard B.
Funding

Funding for this research was provided by:

Vertex Pharmaceuticals
License Information

Text and Data Mining valid from 2020-09-23

Version of Record valid from 2020-09-23
More Information

Article History

Received: 28 July 2020

First Online: 23 September 2020

Document is current